1. Home /
  2. Litigation

Litigation

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.

Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy

Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy

Shares of drugmaker Mallinckrodt plunge on a report the company is considering filing for bankruptcy as a way of dealing with its opioid-related legal liabilities.

MillerCoors Wins Injunction Against Bud Light's `No Corn Syrup' Claims

MillerCoors Wins Injunction Against Bud Light's `No Corn Syrup' Claims

MillerCoors had contended that its rival used "false and misleading" advertising to imply its brews include a potentially fattening form of corn syrup.

Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation

Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation

Allergan announces it has reached a settlement with two plaintiffs in Ohio in the multi-district federal litigation over opioids.

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.

Johnson & Johnson Is in the News, but How Do the Charts Look?

Johnson & Johnson Is in the News, but How Do the Charts Look?

I am not focused on today's price movement of the stock but the pattern from the end of 2017.

Johnson & Johnson Faces Oklahoma Opioid Ruling on Monday

Johnson & Johnson Faces Oklahoma Opioid Ruling on Monday

An Oklahoma judge is expected to issue what will be a landmark ruling Monday on whether Johnson & Johnson will be held responsible for the state's opioid epidemic that officials say led to more than 6,000 deaths over nearly two decades.

Tesla's Solar Division Under Fire for Roof Blazes at Walmart

Tesla's Solar Division Under Fire for Roof Blazes at Walmart

The news comes the same week that Tesla CEO Elon Musk announced a solar panel rental program that seemed designed to boost business at the division.

Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon

Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon

Understanding yourself and the investing environment you are in are keys to avoiding panic brought on by fear.